The Intensive Comprehensive Aphasia Program (ICAP): A Randomized Clinical Trial - Rehabilitation Institute of Chicago

Skip to Content

The Intensive Comprehensive Aphasia Program (ICAP): A Randomized Clinical Trial

Objective

This study is a randomized clinical trial that compares the efficacy and cost-effectiveness of an Intensive Comprehensive Aphasia Program that provides 60 hours of intensive treatment over three weeks (i.e. 4 hours a day, 5 days a week for 3 weeks) to rehabilitation that provides the same amount and type of comprehensive treatment but is distributed over 15 weeks (i.e. 2 hours, twice a week for 15 weeks).  

IRB Protocol Number
STU00201361
Principal Investigator(s)
Leora Cherney

Clinical Trial Categories

  • Brain Injury Research
  • Stroke Research
  • Aphasia Research

Compensation

  • Provided
Sponsor(s)
The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)
Contact
Edie Babbitt at 312-238-6163
or ebabbitt@ric.org
Who Can Participate

Who Can Participate

  • Adults with aphasia caused by a single stroke
  • Right-handed prior to stroke

 

Compensation

 Provided

  • $25 for each assessment visit
  • $15 for each treatment visit
  • Total: $350 for 3-week group and $575 for 15-week group